Open Access

Add on to take back control: Combining lipid lowering therapies for the management of high risk patients

Event: ESC CONGRESS 2020 - The Digital Experience
Topic: Drug therapy
Session type: Industry Q&A session
Sponsored by Daiichi Sankyo Europe GmbH
Date: 31 August 2020
Time: 12:45 - 13:45

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

5 presentations in this session

Welcome and introduction.

Speaker: Professor J. Chapman (Paris, FR)
Speaker: Professor L. Tokgozoglu (Ankara, TR)
Thumbnail

New guidelines: Importance to reduce LDL-C in patients at risk.

Speaker: Professor L. Masana (Reus, ES)
Thumbnail

The role of add-on therapies in the management of high and very high CV risk patients.

Speaker: Professor P. Perrone-Filardi (Naples, IT)
Thumbnail

Novel options for the combination of LDL-C lowering therapies.

Speaker: Professor K. Ray (London, GB)
Thumbnail

Live Q & A with chairmen & speakers.

Speaker: Professor L. Tokgozoglu (Ankara, TR)
Speaker: Professor J. Chapman (Paris, FR)
Thumbnail

7 speakers from this session

Professor John Chapman

Sorbonne University, Paris (France)
15 presentations
0 follower

Professor Lale Tokgozoglu

Hacettepe University, Ankara (Turkey)
26 presentations
0 follower

Professor Luis Masana

University Hospital Sant Joan de Reus, Reus (Spain)
0 follower

Professor Pasquale Perrone-Filardi

Federico II University Hospital, Naples (Italy)
4 presentations
0 follower

Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
52 presentations
1 follower

Professor Lale Tokgozoglu

Hacettepe University, Ankara (Turkey)
26 presentations
0 follower

Professor John Chapman

Sorbonne University, Paris (France)
15 presentations
0 follower

This platform is supported by

logo Novo Nordisk